Abstract
The “dopamine hypothesis” of schizophrenia has been the predominant guiding theoretical construct for driving studies of the neurobiology of schizophrenia. There has, however, been much interest in the contributions of non-dopamine systems to the clinical symptoms of schizophrenia, in particular, norepinephrine and serotonin. However, direct evidence for altered transmission in monoamine systems has been quite limited. In part this reflects a focus on specific brain regions for different transmitters, in contrast to a “neural systems” approach. Thus, evidence for the dopamine hypothesis has been derived from studies of the basal ganglia in schizophrenic cases and infrequently from other (e.g. cortical) regions. Recent studies have suggested that disturbances in the organization or development of the temporal lobe may underlie certain aspects of the symptoms of schizophrenia In particular, the hippocampus may show cellular loss or disturbances in cell orientation. These results are supported by the work that has identified neuropsychological and in vivo brain disturbances in schizophrenia specific to the medial temporal lobe. However, not all cases show such pathology and it is likely that these disorders could, in addition, involve an important afferent and/or efferent system associated with the temporal lobe. This model is based on the currently held view that parallel cortico-striatal-pallidal-thalamo circuits form an important basis for information processing in the brain. One such circuit involves the primary efferent of the hippocampus, the subiculum, and associated cortical regions that project onto the ventral striatum. Many of the cortical regions that project directly to the ventral striatum also project to the hippocampus via the entorhinal cortex. These include the anterior cingulate, posterior cingulate, superior temporal cortex, and inferior temporal cortex. The ventral striatum, made up of the nucleus accumbens, olfactory tubercle, and ventral putamen, has as its target the ventral pallidum. The ventral pallidum projects to the medial dorsal nuclei of the thalamus, which, in turn, projects to the anterior prefrontal cortical area. This loop has been referred to as the limbic loop. The patterns of innervation and expression of monoamine receptors in the brain have been delineated for the non-human primate and are being unraveled in the human. We, and others, have described the patterns of receptor expression in the limbic circuit. However, few studies have been published to date that detail what the neurochemical counterparts of the neuronal and neuropsychological disturbances in the limbic circuit might be. We have explored the possibility that monoamine systems are altered at more than one synaptic station in this circuit. Results from this laboratory, reviewed here, indicate that the temporal lobe is a site that is particularly sensitive to neurochemical disorganization. The patterns of innervation and the expression of the monoamine receptors in the limbic regions of the brain are altered in schizophrenia. These findings are consistent with the “dopamine hypothesis of schizophrenia” but provide a significantly new perspective. Our research indicates that DA receptor antagonists should exert their anti-psychotic effects by acting in the region of the brain where psychotic symptoms originate (i.e. the temporal lobe/hippocampus). The existence of DA receptors, particularly of the D2 subtype, in the limbic circuits allows antipsychotics to act in the neural circuits that contribute to the symptoms of schizophrenia.
Similar content being viewed by others
References
Aggleton JP, Friedman DP, Mishkin M (1987) A comparison between the connections of the amygdala and hippocampus with the basal forebrain in the macaque. Exp Brain Res 67:556–568
Alexander GE, Crutcher MD (1990) Functional architecture of basal ganglia circuits: neural substrates of parallel processing. TINS 13:266–271
Alexander GE, DeLong MR, Strick PL (1986) Parallel Organization of functionally segregated circuits linking basal ganglia and cortex. Ann Rev Neurosci 9:357–381
Alheid GF, Heimer GL (1988) New perspectives sin basal forebrain organization of special relevance for neuropsychiatric disorders: the striatopallidal, amygdaloid and corticopetal components of substantia innominata. Neuroscience 27:1–39
Amaral DG, Campbell MJ (1986) Transmitter systems in the primate dentate gyrus. Hum Neurobiol 5:169–180
Amaral DG, Insausti R (1990) Hippocampal formation. In: Paxinos G (ed) The human nervous system. Academic Press, San Diego, pp 711–755
Andree TH, Mikuni M, Tong CY, Koenig JY, Meltzer HY (1986) Differential effect of subchronic treatment with various neuroleptic agents on serotonin2 receptors in rat cerebral cortex. J Neurochem 46:191–197
Arango V, Ernsberger P, Marzuk PM, Chen H, Tierney H, Stanley M, Reis DJ, Mann JJ (1990) Autoradiographic demonstration of increased serotonin 5-HT2 and β-adrenergic receptor binding sites in the brain of suicide victims. Arch Gen Psychiatry 47:1038–1047
Arora RC, Meltzer HY (1989) Serotonergic measures in the brains of suicide victims: 5-HT2 binding sites in the frontal cortex of suicide victims and control subjects. Am J Psychiatry 146:730–736
Bacopoulas NG, Spokes EG, Bird ED, Roth RH (1979) Antipsychotic drug action in schizophrenic patients: effect of cortical dopamine metabolism after long-term treatment. Science 205:1405–1407
Benes FM, Vincent SL, Alsterberg G, Bird ED, SanGiovanni JP (1992) Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics. J Neurosci 12:924–929
Bennett JP, Enna SJ, Bylund DB, Gillin JC, Wyatt RJ, Snyder SH (1979) Neurotransmitter receptors in frontal cortex of schizophrenics. Arch Gen Psychiatry 36:927–934
Berger B, Gaspar P, Verney C (1991) Dopaminergic innervation of the cerabral cortex: unexpected differences between rodents and primates. TINS 14:21–27
Besson MJ, Graybiel AM, Nastuk MA (1988) [3H]SCH 23390 binding to D1 dopamine receptors in the basal ganglia of the cat and primate: delineation of striosomal compartments and pallidal and nigral subdivisions. Neuroscience 26:101–119
Bird EO, Spokes EG, Iversen LL (1979) Brain norepinephrine and dopamine in schizohrenia. Science 204:456
Bleich A, Brown S, Kahn R, Van Praag HM (1988) The role of serotonin in schizophrenia. Schizophr Bull 14:287–315
Bogerts B, Hantsch J, Herzer M (1983) A morphometric study of the dopamine-containing cell groups in the mesencephalon of normals, Parkinson patients, and schizophrenics. Biol Psychiatry 18:951–969
Booze RM, Crisostomo EA, Davis JN (1989) Species differenes in the localization and number of CNS beta adrenergic receptors: rat verus guinea pig. J Pharmacol Exp Ther 249:911–919
Bowers MB (1987) The role of drugs in the production of schizophreniform psychoses and related isorders. In: Meltzer HV (ed) Psychopharmacology the third generation of progress. Raven Press, New York, pp 819–812
Bruton CJ, Crow TJ, Frith CD, Johnstone EC, Owens DGC, Robert GW (1990) Schizophrenia and the brain: a prospective clinico-neuropathological study. Psychol Med 20:285–304
Carenzi A, Gillin JC, Guidotti A, Schwartz MA, Trabucchi M, Wyatt RJ (1975) Dopamine-sensitive adenylyl cyclase in human caudate nucleus. Arch Gen Psychiatry 32:1056–1059
Carlsson A, Lindqvist M (1963) Effect of chlorpromazine of halperidol on formation of 3'-methyoxytyramine and normetanephrine in mouse brain. Acta Pharmacol Toxicol 20:140–144
Carlsson M, Carlsson A (1990) Schizophrenia: a subcortical neurotransmitter inbalance syndrome? Schizophr Bull 16:425–432
Castelao JF, Ferreira L, Gelder YG, Heylen SL (1989) The efficacy of the D2 and 5-HT2 antagonist risperidone (R 64,766) in the treatment of chronic psychosis. An open dose-fidning study. Schizophr Res 2:411–415
Chen JF, Weiss B (1991) Ontogenetic expression of D2 dopamine receptor mRNA in rat corpus striatum. Dev Brain Res 63:95–104
Chubakov AR, Gromova EA, Gromova GV, Sarkisova EF, Chumasov EI (1986) The effects of serotonin on the morpho-functional development of rat cerebral neocortex in tissue culture. Brain Res 369:285–297
Cortés R, Gueye B, Pazos A, Probst A, Palacios JM (1989) Dopamine receptors in human brain: autoradiographic distribution of D1 sites. Neuroscience 28:263–273
Creese I, Burt DR, Snyder SH (1976) Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192:596–598
Cross AJ, Crow TJ, Ferier IN, Johnson EC, McCreadie RM, Owen F, Owen DGC, Poulter M (1983) Dopamine receptor changes in schizophrenia in relation to the disease process and movement disorder. J Neural Transm Suppl 18:265–272
Crow TJ (1982) The biology of schizophrenia. Experientia 38:1275–1282
Crow TJ, Baker H, Gross A, Joseph M, Lofthouse R, Longden A, Owen F, Riley G, Glover V Killpack W (1979) Monoamine mechanisms in chronic schizophrenia: post-mortem neurochemical findings. Br J Psychiatry 134:249–256
Crow TJ (1980) Molecular pathology of schizophrenia: more than one disease process? Brit J Psychiatry 145:243–253
Crow TJ, Owen F, Cross AJ, Ferrier IN, Johnstone EC, McCreadie RG, Owens DG, Poulter M (1981) Neurotransmitter enzymes and receptors in post-mortem brain in schizophrenia: evidence that an increase in D2 receptors is associated with the type I syndrome. In: Riedere P, Usdin E (eds) Transmittetr biochemistry of human brain tissue. Macmillan, London, pp 85–96
Crow TJ, Cross AJ, Cooper SJ, Deakin JFW, Ferrier IN, Johnson, Joseph MJ, Owen F, Poulter M, Lofthouse R, Corsellis JAN, Chambers DRB, Perry EK, Perry RH, Tomlinson BE (1984) Neurotransmitter receptors and monoamine metabolites in brains of patients with Alzheimer-type dementia and depression, and suicides. Neuropharmacology 23:1561–1569
Csernansky JG, Murphy GM, Faustman WO (1991) Limbic/mesolimbic connections and the pathogenesis of schizophrenia. Biol Psychiatry 30:383–400
Czudek C, Reynolds GP (1989) [3H]GBR 12935 binding to the dopamine uptake site in post-mortem brain tissue in schizophrenia. J Neural Transm 77:227–230
D'Amato RJ, Blue ME, Largent BL, Lynch BR, Ledbetter DJ, Molliver ME, Snyder SN (1987a) Ontogeny of the serotonergic projection to rat neocortex: transient expression of a dense innervation into primary sensory areas. Proc Natl Acad Sci USA 84:4322–4326
D'Amato RJ, Largent BL, Snowman AM, Snyder SH (1987b) Selective labeling of serotonin uptake sites in rat brain by [3H]citalopram contrasted to the labeling of multiple sites by [3H]imipramine. J Pharmacol Exp Ther 242:364–371
De Paermentier, F, Cheetham SC, Cromptom MR, Horton RW (1989) β-Adrenoceptors in human brain labelled with [3H]dihydroalprenolol and [3H]CGP 12177. Eur J Pharmacol 167:397–405
DeLong MR (1990) Primate models of movement disorders of basal ganglia origin. TINS 13:281–285
Dewar KM, Soghomonian J, Bruno JP, Descarries LR (1990) Elevation of dopamine D2 but not D1 receptors in adult rat striatum after neonatal 6-hydroxydopamine denervation. Brain Res 536:287–296
Donlon PT, Stenson RL (1976) Neuroleptic induced extrapyramidal symptoms. Dis Nerv Syst 37:629–635
Fallon JH, Moore RY (1978) Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum. J Comp Neurol 180:545–580
Farley IJ, Price KS, McCullough E, Deck HHN, Hordynksi O, Hornykiewicz O (1979) Norepinephrine in chronic paranoid schizophrenia: above-normal levels in limbic forebrain. Science 200:456–458
Farley IJ, Shannak K, Hornykiewicz D (1980) Brain monoamine changes in chronic paranoid schizophrenia and their possible relation to increased dopamine receptor sensitivity. In: Pepeu G, Kuhar M, Enna S (eds) Receptors for neurotransmitters and peptide hormones. Raven Press, New York, pp 427–433
Fiedler EP, Marks MJ, Collins AC (1987) Postnatal development of cholinergic enzymes and receptors in mouse brain. J Neurochem 49:983–990
Fishell G, Van der Kooy D (1987) Pattern formation in the striatum: developmental changes in the distribution of striatonigral neurons. J Neurosci 7:1969–1978
Frazer A, Offord SJ, Lucki I (1988) Regulation of serotonin receptors and responsiveness in the brain. In: Sanders-Bush E (ed) The serotonin receptors. The Humana Press, pp 319–362
Frazer A, Maayani S, Wolfe BB (1990) Subtypes of receptors for serotonin. Annu Rev Pharmacol Toxicol 30:307–348
Friedman HR, Goldman-Rakic PS (1988) Activation of the hippocampus and dentate gyrus by working-memory: a 2-deoxyglucose study of behaving rhesus monkeys. J Neurosci 8:4693–4706
Frielle T, Kobilka B, Lefkowitz RJ, Caron MG (1988) Human β1-and β2-adrenergic receptors: Structurally and functionally related receptors derived from distinct genes. TINS 11:321–323
Gaspar P, Berger B, Febvret A, Vigny A, Henry JP (1989) Catecholamine innervation of the human cerebral cortex as revealed by comparative immunohistochemistry of tyrosine hydroxylase and dopamine-beta-hydroxylase. J Comp Neurol 279:249–271
Gaspar P, Duyckaerts C, Alvarez C, Javoy-Agid F, Berger B (1991) Alterations of dopaminergic and noradrenergic innervations in motor cortex in Parkinson's disease. Ann Neurol 30:365–374
Gerfen CR, Herkenham M, Thiabault J (1987a) The neostriatal mosaic II. Patch- and matrix-directed mesostriatal dopaminergic and non-dopaminergic systems. J Neurosci 7:3915–3934
Gerfen CR, Baimbridge KG, Thibault J (1987b) The neostriatal mosaic: III. Biochemical and developmental dissociation of patch-matrix mesostriatal systems. J Neurosci 7:3935–3944
Goedart M, Mantyh PW, Emson PS, Hunt SP (1984) Inverse relationship between neurotensin receptors and neurotensin-like immunoreactivity in cat striatum. Nature 307:543–546
Goldman PS, Nauta WJH (1977) Columnar distribution of corticocortical fibers in the frontal association, limbic and motor cortex of the developing rhesus monkey. Brain Res 122:393–413
Goldman-Rakic PS (1982) Cytoarchitectonic heterogeneity of the primate neostriatum-subdivision into island and matrix cellular compartments. J Comp Neurol 205:398–413
Goldman-Rakic PS, Lidow MS, Gallager DW (1990) Overlap of dopaminergic, adrenergic, and serotoninergic receptors and complementarity of their subtypes in primate prefrontal cortex. J Neurosci 10:2125–2138
Gozlan H, El Mestikawy S, Pichat L, Glowinki J, Hamon M (1983) Identification of presynaptic serotonin autoreceptors using a new ligand:3H-DPAT. Nature 305:140–142
Graybiel AM (1984) Correspondence between the dopamine islands and striosomes of the mammalian striatum. Neuroscience 13:1157–1187
Graybiel AM (1986) Neurochemically specified subsystems in the basal ganglia. Ciba Foundation Symposium 107:114–149
Graybiel AM (1990) Neurotransmitters and neuromodulators in the basal ganglia. TINS 13:244–254
Graybiel AM, Chesselet M (1984) Compartmental distribution of striatal cell-bodies expressing [Met]enkephalin like immunoreactivity. Proc Natl Acad Sci USA 81:7980–7984
Graybiel AM, Ragsdale CW (1978) Histochemically distinct compartments in striatum of human, monkey and cat demonstrated by acetyliocholinesterase staining. Proc Natl Acad Sci USA 74:5723–5726
Graybiel AM, Ragsdale CWJ, Yoneoka ES, Elder RP (1981) An immunohisto-chemical study of enkephalins and other neuropeptides in the striatum of the cat with evidence that the opiate receptors are arranged to form mosaic patterns in register with the striosomal compartmens visible by acetylcholinesterase staining. Neuroscience 6:377–397
Graybiel AM, Baughman RW, Eckenstein F (1986) Cholinergic neuropil of the striatum observes striosomal boundaries. Nature 323:625–627
Graybiel AM, Hirsch EC, Agid YA (1987) Differences in tyrosine hydroxylase-like immunoreactivity characterize the mesostriatal innervation of striosomes and matrix at maturity. Proc Natl Acad Sci USA 84:303–307
Graybiel AM, Liu G, Dunnett SB (1989) Intrastriatal grafts derived from fetal striatal primordia. I. phenotypy and modular organization. J Neurosci 9:3250–3271
Gromova HA, Chubakov AR, Chumasov EI, Konovalov HV (1983) Serotonin as a stimulator of hippocampal cell differentiation in tissue culture. Int J Dev Neurosci 1:339–349
Gross-Isseroff R, Israeli M, Biegon A (1988) Autoradiographic analysis of [3H]desmethylimipramine binding in the human brain postmortem. Brain Res 456:120–126
Gross-Isseroff R, Israeli M, Biegon A (1989) Autoradiographic analysis of tritiated imipramine binding in the human brain post mortem: effects of suicide. Arch Gen Psychiatry 46:237–241
Gross-Isseroff R, Salama D, Israeli M, Biegon A (1990) Autoradiographic analysis of age-dependent changes in serotonin 5-HT2 receptors of the human brain postmortem. Brain Res 519:223–227
Haber SN (1986) Neurotransmitters in the human and nonhuman primate basal ganglia. Hum Neurobiol 5:159–168
Hall MD, El Mestikawy S, Emerit MB, Pichat L, Hamon M, Gozlan H (1985)3H-8-Hydroxy-2-(di-n-propylamino)tetralin-bindg to pre-and post-synaptic 5-hydroxytryptamine binding sites invarious regions of the rat brain. J Neurochem 44:1685–1696
Heimer L, Wilson RD (1975) The subcortical projections of the allocortes: similarities in the neural associations of the hippocampus, the priform cortex, and the neocortes. In: Santini M (ed) Golgi Centennial symposium. Raven Press, New York, pp 177–193
Heimer L, Alheid GF, Zaborszky L (1985) Basal ganglia. In: Paxinos G (ed) The rat nervous system, vol 1. Forebrain and midbrain. Academic Press, Australia, pp 37–86
Herkenham M, Pert CB (1981) Mosiac distribution of opiate receptors, parafascicular projections and acetylcholinesterase in rat striatum. Nature 291:415–417
Hess EJ, Bracha HS, Kleinman JS, Creese I (1987) Dopamine receptor subtype imbalance in schizophrenia. Life Sci 40:1487–1497
Hirai M, Kitamura N, Hashimoto T, Nakai T, Shirakawa O, Yamadori O, Amano T, Noguchi-Kuno SA, Tanaka C (1988) [3H]GBR-12935 binding sites in human striatal membranes: binding characteristics and changes in parkinsonians and schizophrenics. Jpn J Pharmacol 47:237–243
Hornykiewicz O (1973) Parkinson's disease: from brain homogenate to treatment. Fed Proc 32:183–190
Hornykiewicz O (1982) Brain catecholamines in schizophrenia — a good case for noradrenaline. Nature 299:484–485
Hoyer D, Pazos A, Probst A, Palacios JM (1986) Serotonin receptors in the human brain. I. Characterization and autoradiographic localization of 5-HT1A recognition sites. Apparent absence of 5-HT1B recognition sites. Brain Res 376:85–96
Hoyer D, Pazos A, Probst A, Palacios JM (1986) Serotonin receptors in the human brain. II. Characterization and autoradiographic localization of 5-HT1C and 5-HT2 recognition sites. Brain Res 376:97–107
Humphrey T (1967) The development of the human hippocampal fissure. J Anat 101:655–676
Hurtig H, Joyce JN, Sladek JRJ, Trojanowski JW (1989) Postmortem analysis of adrenal-medulla-to-caudate autograft in a patient with Parkinson's disease. Ann Neurol 25:607–614
Ikegami H, Prasad C (1990) Neuropeptide-dopamine interactions. V. Cyclo(His-Pro) regulation of striatal dopamine transporter complex. Peptides 11:145–148
Innausti R, Amaral DG, Cowan WM (1987) The enorhianl cortes of the monkey: II. cortical afferents. J. Comp Neurol 264:356–395
Jimenez-Castellanos J, Graybiel AM (1987) Subdivisions of the dopamine-containing A8-A9-A10 complex identified by their differential mesostriatal innervation of striosomes and extrastriosomal matrix. Neuroscience 23:223–242
Joseph MH, Baker HF, Crow TJ, Riley GJ, Rigsby D (1979) Brain tryptophan metabolism in schizophrenia: a posmortem study of metaboliyes on the serotonin and kynurenine pathways in schizophrenic and control subjects. Psychopharmacology 62:279–285
Joyce JN (1991) Differential response of striatal dopamine receptor subtypes and cholinergic muscarinic receptors to the loss of dopamine: I. Effects of intranigral or intracerebroventricular 6-hydroxydopamine lesions of the mesostriatal dopamine system. Exp Neurol 113:261–276
Joyce JN, Hurtig H (1990) Differential regulation of striatal dopamine D1 and D2 receptor systems in Parkinson's disease and effects of adrenal medullary transplant. Prog Brain Res 82:699–706
Joyce JN, Sapp DW, Marshall JF (1986) Human striatal dopamine receptors are organized in compartments. Proc Natl Acad Sci USA 83:8002–8006
Joyce JN, Lexow N, Bird E, Winokur A (1988a) Organization of dopamine D1 and D2 receptors in human striatum: receptor autoradiographic studies in Huntington's disease and schizophrenia. Synapse 2:546–557
Joyce JN, Lexow N, Neal B, Winokur A (1988b) Dopaminergic, serotonergic, cholinergic and β-adrenergic systems in normal and schizophrenic striatum with reference to striosome/matrix compartments. Soc Neurosci Abstr 14:720
Joyce JN, Janowsk A, Neve KA (1991) Characterization and distribution of [125I]epidepride binding to dopamine D2 receptors in basal ganglia and cortex of human brain. J Pharmacol Exp Ther 253:1253–1263
Joyce JN, Lexow N, Kim SJ, Artymysh R, Cassanova M, Kleinman J, Bird E, Winokur A (1992) Distribution of beta-adrenergic receptor subtypes in human post-mortem brain: alterations in limbic regions of schizophrenics. Synapse 10:228–246
Joyce JN, Shane A, Lexow N, Winokur A, Casanova MF, Kleinman JE (1993) Serotonin uptake sites and serotonin receptors are altered in limbic system of schizophrenics. Neuropsychopharmacol (in press)
Kellar KJ, Stockmeier CA, Tainvow TC, Wolfe BB (1985) Electroconvulsive shock selectively down-regulates beta-1 adrenergic receptors in specific areas of rat brain. Soc Neurosci Abstr 11:812
Kelley AE, Domesick VB, Nauta WHJ (1982) The amygdalostriatal projection in the rat-an anatomical study by anterograde and retrograde tracing methods. Neuroscience 7:615–630
Kleinman JE, Karoum F, Rosenblatt JE, Gillin JC, Hong J, Bridge TP, Zalcman S, Del Carmen R, Wyatt RJ (1982) Postmortem neurochemical studies in chronic schizophrenia. In: Usdin E, Hanin I (eds) Biological markers in psychiatry and neurology. Pergamon Press, Oxford, pp 67–76
Korpi ER, Kleinman JE, Goodman SI, Phillips I, DeLisi LE, Linnoila M, Wyatt RJ (1986) Serotonin and 5-hydroxy-indoleacetic acid in the brains of suicide victims: comparison in chronic schizophrenic patients with suicide as cause of death. Arch Gen Psychiatry 43:594–600
Kosofsky BE, Molliver ME (1987) The serotoninergic innervation of cerebral cortex: different classes of axon terminals arise from dorsal and medain raphe nuclei. Synapse 1:153–168
Kostovic I, Seress L, Mrzijak L, Judas M (1989) Early onset of synapse formation in the human hippocampus: a correlation with Nissl-Golgi architectonics in 15- and 16.5 week-old fetuses. Neuroscience 30:105–116
Krettek JE, Price JL (1978) Amygdaloid projections to subcortical structures within the basal forebrain and brainstem in the rat and cat. J Comp Neurol 178:255–280
Lanca AJ, Boyd S, Kolb B, Van der Kooy D (1986) The development of a patchy organization of the rat striatum. Dev Brain Res 27:1–10
Langer LF, Graybiel AM (1989) Distinct nigrostriatal projection systems innervate striosomes and matrix in the priamte striatum. Brain Res 498:344–350
Lauder JM (1990) Ontogeny of the serotonergic system in the rat: serotonin as a developmental signal. Proc NY Acad Sci 600:297–314
Lauder JM, Bloom FE (1975) Ontogeny of monoamine neurons in the locus coeruleus, raphe nuclei and substantia nigra of the rat. I. Cell differentiation. J Comp Neurol 155:469–482
Lavoie B, Parent A (1990) Immunohistochemical study of the serotoninergic innervation of the basal ganglia in the squirrel monkey. J Comp. Neurol 299:1–16
Lee T, Tange SW (1984) Loxapine and clozapine decrease serotonin (S2) but do not elevate dopamine (D2) receptor numbers in the rat brain. Psychiatry Res 12:277–285
Lewis DA, Campbell MJ, Foote SL, Morrison JH (1986) The monoaminergic innervation of the primate neocortex. Hum Neurobiol 5:181–188
Lidov HG, Molliver ME (1982) an immunohistochemical study of serotonin neuron development in the rat: ascending pathways and terminal fields. Brain Res Bull 8:389–430
Lidow MS, Goldman-Rakic PS, Gallager DW, Rakic P (1989) Quantitative autoradiographic mapping of serotonin 5-HT1 and 5-HT2 receptors and uptake sites in the neocortex of the rhesus monkey. J Comp Neurol 280:27–42
Lidow MS, Goldman-Rakic PS, Rakic P (1991) Synchronized over-production of neurotransmitter receptors in diverse reigons of the primate cerebral cortex. Proc Natl Acad Sci USA 88:10218–10221
Lohr JB, Jeste DV (1988) Locus ceruleus morphometry in aging and schizophrenia. Acta Psychiatr Scand 77:689–697
Lowenstein PR, Slesinger PA, Singer HS, Walker LC, Casanova MF, Raskin LS, Price DL, Coyle JT (1989) Compartment specific changes in the density of choline and dopamine uptake sites and muscarinic and dopaminergic receptors during the development of the baboon striatum: a quantitative receptor autoradiographic study. J Comp Neurol 288:428–446
Lowenstein PR, Joyce JN, Coyle JT, Marshall JF (1990) Striosomal organization of cholinergic and dopaminergic uptake sites and cholinergic M1 receptors in the adult human striatum: a quantitative receptor autoradiographic study. Brain Res 510:122–126
Lüders H, Lesser RP, Hahn J, Dinner DS, Morris HH, Wyllie EG (1991) Basal temporal language area. Brain 114:743–754
Mackay AVP, Iversen L, Rossor M, Spokes E, Bird E, Arregui A, Creese I, Snyder SH (1982) Increased brain dopamine and dopamine receptors in schizophrenia. Arch Gen Psychiatry 39:991–997
Mamounas LA, Mullen CA, O'Hearn E, Molliver ME (1991) Dual serotoninergic projections to forebrain in the rat: morphologically distinct 5-HT axon terminals exhibit differential vulnerability to neurotoxic amphetamine derivatives. J Comp Neurol 314:558–586
Mann JJ, Arango AN (1988) CNS adrenergic receptor and beta blockade. Postgrad Med 29:135–139
Mann JJ, Stanley M, McBride PA, McEwen BS (1986) Increases serotonin2 and beta-adrenergic receptor binding in the frontal cortices of suicide victims. Arch Gen Psychiatry 43:954–959
Marshall JF, Navarrete R, Joyce JN (1989) Decreased striatal D1 binding density following mesotelencephalic 6-hydroxydopamine injections: an autoradiographic analysis. Brain Res 493:247–257
Marshall JF, O'Dell SJ, Navarrete R, Rosenstein AJ (1990) Dopamine high-affinity transport site topography in rat brain: major differences between dorsal and ventral striatum. Neuroscience 37:11–21
Martin LJ, Hadfield MG, Dellovade TL, Price DL (1991) The striatal mosaic in primates: patterns of neuropeptide immunoreactivity differentiate the ventral striatum from the dorsal striatum. Neuroscience 43:397–417
Masudi NA, Gilmore DP (1983) Biogenic amine levels in the midterm human foetus. Dev Brain Res 7:9–12
Meltzer HY (1989) Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia. Psychopharmacology 99:S18-S27
Memo M, Kleinman JE, Hanbauer AI (1983) Coupling of dopamine D1 recognition sites with adenylate cyclase in nuclei accumbens and caudatus of schizophrenics. Science 221:1304–1307
Minneman KP, Dibner MD, Wolfe BB, Molinoff PB (1979a) β1-and β2-adrenergic receptors in rat cerebral cortex are independently regulated. Science 204:866–868
Minneman KP, Hegstrand LR, Molinoff PB (1979b) Simulteneous determination of β1- and β2-adrenergic receptors in tissue containing both receptor subtypes. Mol Pharmacol 16:34–46
Mishkin M (1982) A memory system in the monkey. Philos Trans R Soc Lond 298:85–95
Mita T, Hanada S, Nishino N, Kuno T, Nakai H, Yamadori T, Mizoi Y, Tanaka C (1986) Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics. Biol Psychiatry 21:1407–1414
Murrin LC, Ferrer JA (1984) Ontogeny of the striatum: correspondence of dopamine terminals, opiate receptors and acetyl-cholinesterase. Neurosci Lett 47:155–160
Nastuk MA, Graybiel AM (1988) Autoradiographic localization and biochemical characteristics of M1 and M2 muscarinic binding sites in the striatum of the cat, monkey, and human. J Neurosci 8:1052–1062
Neal BS, Joyce JN (1991a) D1 and D2 receptor do not nup-regulate in response to neonatal intrastriatal 6-hydroxydopamine (6-OHDA) lesions. Soc Neurosci Abstr 17:610
Neal BS, Joyce JN (1991b) Dopamine D1 receptor behavioral responsitivity following selective lesions of the striatal patch compartment during development. Dev Brain Res 60:105–113
Neal BS, Joyce JN (1992) Neonatal 6-OHDA lesions differentially affect striatal D1 and D2 receptors. Synapse 11:35–46
Niznik HB, Tyndale RF, Sallee FR, Gonzalez FJ, Hardwick JP, Inaba T, Kalow W (1990) The dopamine transporter and cytochrome P45OIID1 (debrisoquine 4-hydroxylase) in brain: resolution and identification of two distinct [3H]GBR-12935 binding proteins. Arch Biochem Biophys 276:424–432
Nobin A, Björklund A (1973) Topography of the monoamine neuron systems in the human brain as revealed in fetuses. Acta Physiol Scand 388:1–30
O'Dell SJ, La Hoste GJ, Widmark CV, Shapiro RM, Potkin SG, Marshall JF (1990) Chronic treatment with clozapine or haloperidol differentially regulates dopamine and serotonin-receptor in rat brain. Synapse 6:146–153
Olson L, Seiger A, Fuxe K (1972) Heterogeneity of striatal and limbic dopamine innervation: highly fluorescent islands in developing and adult rats. Brain Res 44:283–288
Olson L, Boreus LO, Seiger A (1973) Histochemical demonstration and mapping of 5-hydroxytryptamine and catecholamine-containing neuron systems in the human fetal brain. Z Anat Entw Gesch 139:259–282
Pakkenberg B (1987) Postmortem study of chronic schizophrenic brains. Br J Psychiatry 151:744–752
Pazos A, Palacios JM (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonoin-1 receptors. Brain Res 346:205–230
Pazos A, Cortés R, Palacios JM (1985a) Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors. Brain Res 346:231–249
Pazos A, Probst A, Palacios JM (1985b) β-Adrenoceptor subtypes in the human brain: autoradiographic localization. Brain Res 358:324–328
Pazos A, Probst A, Palacios JM (1987a) Serotonin receptors in the human brain-III. Autoradiographic mapping of serotonin-1 receptors. Neuroscience 21:97–122
Pazos A, Probst A, Palacios JM (1987b) Serotonin receptors in the human brain-IV. Autoradiographic mapping of serotonin-2 receptors. Neuroscience 21:123–139
Pearce RK, Seeman P, Jellinger K, Tourtellotte KW (1990) Dopamine uptake sites and dopamine receptors in Parkinson's disease and schizophrenia. Eur Neurol Suppl 1:9–14
Pickar D, Labarca R, Linnoila M, Roy A, Hommer D, Everett DP (1984) Neuroleptic-induced decrease in plasma HVA and antipsychotic activity in schizophrenic patients. Science (NY) 225:954–957
Ragsdale CWJ, Graybiel AM (1988) Fibers from the basolateral nucleus of the amygdala selectively innervate striosomes in the caudate nucleus of the cat. J Comp Neurol 269:506–522
Ragsdale CWJ, Graybiel AM (1990) A simple ordering of neocortical areas established by the compartmental organizatio of their striatal projections. Proc Natl Acad Sci USA 87:6196–6199
Rainbow TC, Parsons B, Wolfe BB (1984) Quantitative autoradiography of β1- and β2-adrenergic receptors in rat cerebellum and cerebral cortex. Proc Natl Acad Sci USA 81:1585–1589
Rakic P, Bourgeois J, Eckenhoff MF, Zecevic N, Goldman-Rakic PS (1986) Concurrent overproduction of synapses in diverse regions of the primate cerebral cortex. Science 232:232–235
Rao PA, Molinoff PB, Joyce JN (1991) Ontogeny of dopamine D1 and D2 receptor subtypes in rat basal ganglia: a quantitative autoradiographic study. Dev Brain Res 60:167–177
Reynolds GP (1983) Increased concentrations and lateral asymmetry of amygdala dopamine in schizophrenia. Nature 305:527–529
Reynolds GP (1989) Beyond the dopamine hypothesis. The neurochemical pathology of schizophrenia. Br J Psychiatry 155:305–316
Reznikoff GA, Manaker S, Rhodes CH, Winokur A, Rainbow TC (1986) Localization and quantification of beta-adrenergic receptors in human brain. Neurology 36:1067–1073
Rhodes KJ, Joyce JN, Sapp DW, Marshall JF (1987) [3H]Hemicholinium-3 binding in rabbit striatum: correspondence with patchy acetylcholinesterase staining and a method for quantifying striatal compartments. Brain Res 412:400–404
Richfield EK, Young AB, Penney JB (1989) Comparative distribution of D-1 and D-2 receptors in the cerebral cortex of turtles, pigeons, rats, cats, and monkeys. J Comp Neurol 286:409–426
Rosene DL, Van Hoesen GW (1987) The hippocampal formation of the primate brain. A review of some comparative aspects of cytoarchitecture and connections. In: Jones EG, Peters A (eds) Cerebral cortex, vol 6. Plenum Press, New York, pp 345–456
Rosengarten H, Friedhoff AJ (1979) Enduring changes in dopamine receptor cells of pups from drug administration to pregnant and nursing rats. Science 203:1133–1135
Roy A (1984) Attempted suicide in chronic schizophrenia. Br J Psychiatry 144:303–306
Saunders RC, Rosene DL (1988) A comparison of the efferents of the amygdala and the hippocampal formation in the rhesus monkey: I. Convergence in the entorhinal, prorhinal and perirhinal cortices. J Comp Neurol 271:153–184
Saunders RC, Rosene DL, Van Hoesen GW (1988) Comparison of the efferents of the amygdala and the hippocampal formation in the rhesus monkey: II. Reciprocal and non-reciprocal connections. J Comp Neurol 271:185–207
Schotte A, Maloteaux JM, Laduron PM (1983) Characterization and regional distribution of serotonin S2-receptors in human brain. Brain Res 276:231–235
Schweri MM, Jacobson AE, Lessor RA, Rice KC (1989) Metaphit inhibits dopamine transport and binding of [3H]methylphenidate, a proposed marker for the dopamine transport complex. Life Sci 45:1689–1698
Seeman P, Niznik HB (1990) Dopamine receptors and transporters in Parkinson's disease and schizophrenia. FASEB J 4:2737–2744
Seeman P, Lee T, Chau-Wong M, Wong K (1976) Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 261:717–719
Seeman P, Bzowej NH, Guan HC, Bergeron C, Reynolds GP, Bird ED, Riederer P, Jellinger K, Tourtellote WW (1987) Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's and Huntington's disease. Neuropsychopharmacol 1:5–15
Shaw C, Wilkinson M, Cynader MC, Needler C, Aokic, Hall SE (1986) the laminar distributions and postnatal development of neurotransmitter and neuromodulator receptors in cat visual cortex. Brain Res Bull 16:661–671
Shaw C, Aoki C, Wilkinson M, Prusky G, Cynader M (1987) Benzodiazepine ([3H]blunitrazepam) binding in car visual cortex: ontogenesis of normal characteristics and the effects of dark rearing. Dev Brain Res 37:67–76
Shimizu I, Prasad C (1991) Relationship between [3H]mazindol binding to dopamine uptake sites and [3H]dopamine uptake in rat striatum during aging. J Neurochem 56:575–579
Slessinger PA, Lowenstein PR, Singer HS, Walker LC, Casanova MF, Price DL, Coyle JT (1988) Development of β1- and β2-adrenergic receptors in baboon brain: an autoradiographic study using [125I]Iodocyanopindolol. J Comp Neurol 273:318–329
Snyder-Keller AM (1991) Development of striatal compartmentalization following pre- or postnatal dopamine depletion. J Neurosci 11:810–821
Squire LR (1987) Memory and brain. Oxford University Press, New York
Stachowiak MK, Bruno JP, Snyder AM, Stricker EM, Zigmond MJ (1984) Apparent sprouting of striatal serotonergic terminals after dopamine-depleting brain lesions in neonatal rats. Brain Res 291:164–167
Stanley M, Virgilio J, Gushon S (1982) Tritiated imipramine binding sites are decreased in the frontal cortex of suicides. Science 18:1337–1339
Stein L, Wise CD (1971) Possible aetiology of schizophrenia: progressive damage to the noradrenergic reward system by 6-hydroxydopamine. Science 171:1032–1036
Stevens JR (1982) Neuropathology of schizophrenia. Arch Gen Psychiatry 39:1131–1139
Sulser F, Gillespie DD, Manier DH (1984) Physiological mechanism and significance of changes in the regulation of beta adrenoreceptors by antidepressants. Clin Neuropharmacol 7:304–305
Sørensen KE, Witter MP (1983) Entorhinal efferents reach the caudato-putamen. Neurosci Lett 35:259–264
Takahashi H, Nakashima S, Ohama E, Takeda S, Ikuta F (1986) Distribution of serotonin-containing cell bodies in the brainstem of the human fetus determined with immunohistochemistry using antiserotonin serum. Brain Dev 8:355–365
Tennyson VM, Barrett RE, Cohan G, Cote L, Heikkila R, Mytilineou C (1971) The developing neostriatum of the rabbit: Correlation of fluorescence histochemistry, electron microscope, endogenous dopamine levels, and [H3]dopamine uptake. Brain Res 46:251–285
Tillet Y (1987) Immunocytochemical localization of serotonin containing neurons in the myelencephalon, brainstem and diencephalon of the sheep. Neuroscience 23:501–527
Tork I, Hornung JP (1990) Raphe nuclei and serotonin containing systems. In: Paxinos G (ed) The human nervous system. Academic Press, San Diego, pp 1001–1022
Ueda S, Sano V, Kawata M (1991) Collateral sprouting of serotonergic fibers in the cingualte cortex and the septum following cortical-hippocampal lesions. Brain Res 556:329–332
Valverius P, Borg S, Valverius MR, Hoffman PL, Tabakoff B (1989) β-adrenergic receptor binding in brain of alcoholics. Exp Neurol 105:280–286
Van der Kooy D (1984) Developmental relationships between opiate receptors and dopamine in the formation of caudate/putamen patches Dev Brain Res 14:300–303
Van der Kooy D, Fishell G (1987) Neuronal birthdate underlies the development of striatal compartments. Brain Res 401:155–161
Van Hoesen GW (1982) The parahippocampal gyrus. New observation regarding its cortical connections in the monkey. TINS 5:345–350
Van Hoesen GW, Hyman BT, Damasio AR (1991) Entorhinal cortex pathology in Alzheimer's disease. Hippocampus 1:1–8
Vinar O, Molcan J, Nahunek K, Svestka J, Zapletalek M (1989) Ritanserin in schizophrenic patients. Acta Nerv Super 31:107–109
Voorn P, Jorritsma-Byham B, Van Dijk C, Buijs RM (1986) The dopaminergic innervation of the ventral striatum in the rat: a light- and electron-microscopical study with antibodies against dopamine. J Comp Neurol 251:84–99
Voorn P, Kalsbeek A, Jorritsma-Byham B, Groenewegen HJ (1988) The pre- and postnatal development of the dopaminergic cell groups in the ventral mesencephalon and the dopaminergic innervation of the striatum of the rat. Neuroscience 25:857–887
Waeber C, Hoyer D, Palacios JM (1989a) 5-Hydroxytryptamine3 receptors in the human brain: autoradiographic visuliazation suing [3H]ICS 205–930. Neuroscience 31:393–400
Waeber C, Hoyer D, Palacios JM (1989b) GR 43175: A preferential 5-HT1D agent in monkey and human brains as shown by autoradiography. Synapse 4:168–170
Whitaker PM, Crow TJ, Ferrier IN (1981) Tritiated LSD binding in frontal cortex in schizophrenia. Arch Gen Psychiatry 38:278–280
Whitaker-Azmitia PM, Shemer AV, Caruso J, Molino L, Azmitia EC (1990) Role of high affinity serotonin receptors in neuronal growth. Proc NY Acad Sci 600:315–330
Wiklund L, Björklund A (1980) Mechanisms of regrowth in the bulbospinal serotonin system following 5,6-dihydroxytryptamine induced axotomy. II. Fluoresence histochemical observations. Brain Res 191:129–160
Wilmot CA, Szczepanik AM (1989) Effect of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain. Brain Res 487:288–298
Wilson MA, Molliver ME (1991a) The organization of serotonergic projections to cerebral cortex in primates: regional distribution of axon terminals. Neuroscience 44:537–553
Wilson MA, Molliver ME (1991b) The organization of serotonergic projections to cerebral cortex in primates: retrograde transport studies. Neuroscience 44:555–570
Winblad B, Bucht G, Gottfries CG, Roos BE (1979) Monoamines and monoamine metabolites in brains from demented schizophrenics Acta Psychiatr Scand 60:17–28
Wise CD, Stein L (1973) Dopamine-β-hydroxylase deficits in the brains of schizophrenic patients. Science 181:344–347
Witelson SF, Kigar DL (1988) Asymmetry in brain function follows asymmetry in anatomical form: gross, microscopic, postmortem and imaging studies. In: Boller F, Grafman J (eds) Handbook of neuropsychology, vol 1. Elsevier, Amsterdam, pp 111–142
Wolfe BB, Minneman P, Molinoff PB (1982) Selective increases in the density of cerebellar β1-adrenergic receptors. Brain Res 234:474–479
Young AB, Albin RL, Penney JB (1989) Neuropharmacology of basal ganglia functions: relationship to pathophysiology of movement disorders. In: Crossman AR, Sambrook MA (eds) Neural mechanism in disorders of movement. Libbey, London, pp 17–28
Zahm DS (1987) Neurotensin-immunoreactive neurons in the ventral striatum of the adult rat: ventromedial caudate-putamen, nucleus accumbens and olfactory tubercle. Neurosci Lett 81:41–47
Zahm DS (1992) Susbsets of neurotensin-immunoreactive neurons revealed following antagonism of the dopamine-mediated suppression of neurotensin immunoreactivity in the rat striatum. Neuroscience 46:335–350
Zahm DS, Heimer L (1988) Ventral striatopallidal parts of the basal ganglia in the rat: I. Neurochemical compartmentation as reflected by the distributions of neurotensin and substance P immunoreactivity. J Comp Neurol 272:516–535
Zezula J, Cortes R, Probst A, Palacios JM (1988) Benzodiazepine receptor sites in the human brain: autoradiographic mapping. Neuroscience 25:771–795
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Joyce, J.N. The dopamine hypothesis of schizophrenia: limbic interactions with serotonin and norepinephrine. Psychopharmacology 112 (Suppl 1), S16–S34 (1993). https://doi.org/10.1007/BF02245004
Issue Date:
DOI: https://doi.org/10.1007/BF02245004